Mild bronchial asthma: a modern treatment concept
Mild bronchial asthma (BA) occurs in 50–75% of patients with this disease. It is characterized by clinical symptoms that are controlled by low doses of inhaled glucocorticoids (IGCS) or anti-leukotriene drugs. Mild BA reduces the quality of life of patients, is accompanied by the development of seve...
Main Authors: | A. V. Emel’yanov, E. V. Leshenkova, G. R. Sergeyeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2019-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5228 |
Similar Items
-
BRONCHIAL ASTHMA THERAPY IN SMART-REGIME: STUDIES IN REAL CLINICAL PRACTICE
by: R. S. FASSAKHOV
Published: (2016-12-01) -
Optimization of therapy of patients with bronchial asthma in conditions of coronavirus infection
by: E. M. Kostina, et al.
Published: (2021-10-01) -
EXPERIENCE OF LONG-TERM USE OF SYMBICORT IN THE REGIME OF A SIGNLE INHALER FOR BRONCHIAL ASTHMA, INCLUDING DURING PREGNANCY
by: I. I. VORZHEVA
Published: (2016-12-01) -
Pharmacoeconomic aspects of bronchial asthma therapy: real clinical practice
by: A. S. Belevsky, et al.
Published: (2018-10-01) -
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
by: Mohsen Sadatsafavi, et al.
Published: (2021-10-01)